These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 20050918

  • 1. 3T3-L1 adipocyte apoptosis induced by thiazolidinediones is peroxisome proliferator-activated receptor-gamma-dependent and mediated by the caspase-3-dependent apoptotic pathway.
    Xiao Y, Yuan T, Yao W, Liao K.
    FEBS J; 2010 Feb; 277(3):687-96. PubMed ID: 20050918
    [Abstract] [Full Text] [Related]

  • 2. Rosiglitazone and PPAR-gamma overexpression protect mitochondrial membrane potential and prevent apoptosis by upregulating anti-apoptotic Bcl-2 family proteins.
    Wu JS, Lin TN, Wu KK.
    J Cell Physiol; 2009 Jul; 220(1):58-71. PubMed ID: 19229877
    [Abstract] [Full Text] [Related]

  • 3. Downregulation of cyclooxygenase-2 expression and activation of caspase-3 are involved in peroxisome proliferator-activated receptor-gamma agonists induced apoptosis in human monocyte leukemia cells in vitro.
    Liu JJ, Liu PQ, Lin DJ, Xiao RZ, Huang M, Li XD, He Y, Huang RW.
    Ann Hematol; 2007 Mar; 86(3):173-83. PubMed ID: 17089125
    [Abstract] [Full Text] [Related]

  • 4. Thiazolidenediones mediate apoptosis in prostate cancer cells in part through inhibition of Bcl-xL/Bcl-2 functions independently of PPARgamma.
    Shiau CW, Yang CC, Kulp SK, Chen KF, Chen CS, Huang JW, Chen CS.
    Cancer Res; 2005 Feb 15; 65(4):1561-9. PubMed ID: 15735046
    [Abstract] [Full Text] [Related]

  • 5. Loss of XIAP sensitizes colon cancer cells to PPARgamma independent antitumor effects of troglitazone and 15-PGJ2.
    Qiao L, Dai Y, Gu Q, Chan KW, Ma J, Lan HY, Zou B, Rocken C, Ebert MP, Wong BC.
    Cancer Lett; 2008 Sep 18; 268(2):260-71. PubMed ID: 18477501
    [Abstract] [Full Text] [Related]

  • 6. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG, Zhang ZW, Xin DQ, Shi CJ, Wu JP, Guo YL, Guan YF.
    Acta Pharmacol Sin; 2005 Jun 18; 26(6):753-61. PubMed ID: 15916743
    [Abstract] [Full Text] [Related]

  • 7. Guggulsterone inhibits adipocyte differentiation and induces apoptosis in 3T3-L1 cells.
    Yang JY, Della-Fera MA, Baile CA.
    Obesity (Silver Spring); 2008 Jan 18; 16(1):16-22. PubMed ID: 18223606
    [Abstract] [Full Text] [Related]

  • 8. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
    Kong J, Li YC.
    Am J Physiol Endocrinol Metab; 2006 May 18; 290(5):E916-24. PubMed ID: 16368784
    [Abstract] [Full Text] [Related]

  • 9. Apoptosis induced by troglitazone is both peroxisome proliferator-activated receptor-gamma- and ERK-dependent in human non-small lung cancer cells.
    Li M, Lee TW, Yim AP, Mok TS, Chen GG.
    J Cell Physiol; 2006 Nov 18; 209(2):428-38. PubMed ID: 16883598
    [Abstract] [Full Text] [Related]

  • 10. Beyond peroxisome proliferator-activated receptor gamma signaling: the multi-facets of the antitumor effect of thiazolidinediones.
    Weng JR, Chen CY, Pinzone JJ, Ringel MD, Chen CS.
    Endocr Relat Cancer; 2006 Jun 18; 13(2):401-13. PubMed ID: 16728570
    [Abstract] [Full Text] [Related]

  • 11. Hypoglycemic action of thiazolidinediones/peroxisome proliferator-activated receptor gamma by inhibition of the c-Jun NH2-terminal kinase pathway.
    Díaz-Delfín J, Morales M, Caelles C.
    Diabetes; 2007 Jul 18; 56(7):1865-71. PubMed ID: 17416798
    [Abstract] [Full Text] [Related]

  • 12. Differential modulation of COX-2 expression in A549 airway epithelial cells by structurally distinct PPAR(gamma) agonists: evidence for disparate functional effects which are independent of NF-(kappa)B and PPAR(gamma).
    Patel KM, Wright KL, Whittaker P, Chakravarty P, Watson ML, Ward SG.
    Cell Signal; 2005 Sep 18; 17(9):1098-110. PubMed ID: 15993751
    [Abstract] [Full Text] [Related]

  • 13. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells.
    Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, Dong SH, Kim HJ, Chang YW, Chang R.
    Int J Oncol; 2010 Jan 18; 36(1):223-31. PubMed ID: 19956851
    [Abstract] [Full Text] [Related]

  • 14. Effect of pioglitazone, a peroxisome proliferator-activated receptor gamma agonist, on ischemia-reperfusion injury in rats.
    Cao Z, Ye P, Long C, Chen K, Li X, Wang H.
    Pharmacology; 2007 Jan 18; 79(3):184-92. PubMed ID: 17356310
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the growth arrest and DNA damage-inducible gene 45 (GADD45) by peroxisome proliferator-activated receptor gamma in vascular smooth muscle cells.
    Bruemmer D, Yin F, Liu J, Berger JP, Sakai T, Blaschke F, Fleck E, Van Herle AJ, Forman BM, Law RE.
    Circ Res; 2003 Aug 22; 93(4):e38-47. PubMed ID: 12881480
    [Abstract] [Full Text] [Related]

  • 16. Effects of curcumin on peroxisome proliferator-activated receptor gamma expression and nuclear translocation/redistribution in culture-activated rat hepatic stellate cells.
    Cheng Y, Ping J, Xu LM.
    Chin Med J (Engl); 2007 May 05; 120(9):794-801. PubMed ID: 17531121
    [Abstract] [Full Text] [Related]

  • 17. Concentration-dependent stimulatory and inhibitory effect of troglitazone on insulin-induced fatty acid synthase expression and protein kinase B activity in 3T3-L1 adipocytes.
    Barthel A, Krüger KD, Roth RA, Joost HG.
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Apr 05; 365(4):290-5. PubMed ID: 11919653
    [Abstract] [Full Text] [Related]

  • 18. Downregulation of microRNA-29 by antisense inhibitors and a PPAR-gamma agonist protects against myocardial ischaemia-reperfusion injury.
    Ye Y, Hu Z, Lin Y, Zhang C, Perez-Polo JR.
    Cardiovasc Res; 2010 Aug 01; 87(3):535-44. PubMed ID: 20164119
    [Abstract] [Full Text] [Related]

  • 19. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
    Morosetti R, Servidei T, Mirabella M, Rutella S, Mangiola A, Maira G, Mastrangelo R, Koeffler HP.
    Int J Oncol; 2004 Aug 01; 25(2):493-502. PubMed ID: 15254749
    [Abstract] [Full Text] [Related]

  • 20. Very low density lipoprotein receptor promotes adipocyte differentiation and mediates the proadipogenic effect of peroxisome proliferator-activated receptor gamma agonists.
    Tao H, Hajri T.
    Biochem Pharmacol; 2011 Dec 15; 82(12):1950-62. PubMed ID: 21924248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.